Vonoprazan Delivers a Quick, Sustained Relief to NERD Heartburn

Patients with nonerosive reflux disease who can manage their heartburn with daily vonoprazan also report durable ...

OCTOBER 29, 2024

FDA Approves Vonoprazan for NERD

The FDA has approved vonoprazan (Voquezna, Phathom) 10-mg tablets for use in patients with nonerosive reflux ...

JULY 19, 2024

Upcoming H. pylori Guideline Will Have Significant Changes

Treatment guidelines being prepared for release in 2024 are expected to change first- and second-line H. pylori ...

FEBRUARY 22, 2024

P-CABs Rival PPIs for Rapid Healing In Patients With Erosive Esophagitis

Two potassium-competitive acid blockers were associated with a potential healing advantage for erosive esophagitis ...

AUGUST 1, 2023

P-CAB Inhibitor Versus PPI for Preventing Upper GI Rebleeding

Vonoprazan was found to provide the same protection against rebleeding of peptic ulcer hemorrhage after endoscopic ...

JULY 13, 2023

Expert Picks From ACG 2022, Part 2: Esophageal and Liver Care

Brooks D. Cash, MD, discusses his favorite research from ACG 2022, specifically innovations in esophageal and ...

JANUARY 27, 2023

Results of P-CAB Trial Bring Possibility Of a New Therapeutic for NERD

In this edition of “Just a Phase,” we look at a phase 2 trial of vonoprazan as a therapy for nonerosive ...

MAY 18, 2022